Join
Live feed
·
NEWSReleasevia Quantisnow
Pulmatrix Inc. logo

Pulmatrix Stops PUR1900 Phase 2B Study Patient Enrollment And Closing Study, In Agreement With Partner Cipla, To Preserve Cash And Facilitate Strategic Alternatives

ByQuantisnow·Wall Street's wire, on your screen.
PULM· Pulmatrix Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PULM (Pulmatrix Inc.) and more on Quantisnow.